Arosio, M.
Arnaldi, G.
Gasco, V.
Giavoli, C.
Puxeddu, E.
Vettor, R.
Ambrosio, M. R.
Gallinari, P.
Zouater, H.
Fedeli, P.
Ferone, D.
Article History
Received: 3 December 2019
Accepted: 26 May 2020
First Online: 7 June 2020
Compliance with ethical standards
:
: MA, VG, CG, EP, RV, and DF declare that they have no conflicts of interest. GA has received lecture fees from Novartis and Otsuka, and consulting honoraria from HRA Pharma. MRA has received registration fees for scientific meetings from Ipsen, Novartis, Pfizer, and ItaPharma. PG and PF are employees of Sandoz S.p.A, Origgio (MI), Italy. HZ is an employee of Sandoz Biopharmaceutical c/o HEXAL AG, Holzkirchen, Germany.
: The study was approved by each study site’s Independent Ethics Committee or Institutional Review Board before initiation and was conducted in accordance with the Declaration of Helsinki.
: All patients included in the study provided written informed consent at enrolment.